Insiders · UBX

Nathaniel E David

Director at Unity Biotechnology, Inc. (UBX)

Nathaniel E David has filed 5 insider reports with the SEC since February 2021, as director at Unity Biotechnology, Inc. (UBX). The latest filing, on June 21, 2024, reports grant or award at Unity Biotechnology, Inc. (UBX).

Filings
5
Companies
1
Bought on market
None
Sold on market
None

Companies where Nathaniel E David is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Unity Biotechnology, Inc. logo
UBX
Unity Biotechnology, Inc.
DirectorJun 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Nathaniel E David with

Other insiders at the same companies

Questions about Nathaniel E David

What is Nathaniel E David's role at Unity Biotechnology, Inc.?
Nathaniel E David reports to the SEC as director at Unity Biotechnology, Inc. (UBX), according to the latest filing on June 21, 2024.
Has Nathaniel E David bought or sold stock recently?
No open-market purchases or sales by Nathaniel E David are on file. The filings report grant or award.
How do I get alerts when Nathaniel E David files?
Follow Nathaniel E David on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Nathaniel E David (SEC CIK 0001559531). Totals count each trade once, skipping amendments whose original is on file, from Feb 2, 2021 on. View on SEC EDGAR